ATC code - C02AC02
SpainGuanfacine
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,14 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,28 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,42 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,56 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,148 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,296 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,444 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,592 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 5,740 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 6,88 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 8,036 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.